CFO to present at London Investor Show

RNS Number : 8057Q
Surgical Innovations Group PLC
18 October 2013



Surgical Innovations Group plc

("SI" or the "Group")


CFO to present at London Investor Show


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces that Mike Thornton, CFO, of Surgical Innovations, will be presenting on the Company at the London Investor Show on Friday 25 October 2013.


Mike will give a presentation as part of the conference programme. The event is geared towards education, training and networking for private investors and traders.


The event will be held at Level 2, Olympia Central, Hammersmith Road, London, W14 8UX.


For further information, and to register, please go to: 






Surgical Innovations Group plc

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597 or

Mike Thornton, Chief Financial Officer




Panmure Gordon (Nominated Advisor & Broker)

Fred Walsh/ Freddy Crossley (Corporate Finance)

Tel: +44 (0) 20 7886 2500

Adam Pollock/ Victoria Boxall (Corporate Broking)




Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303




Notes to Editors:


About Surgical Innovations Group plc


Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 


For more information, see


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100